Timothy Colin Murray, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Jeffrey A Marsh, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W. Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Ann M Leano, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Hussein Hussein, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Akron, OH 44302 Phone: 330-344-6676 |
Harish Kakarala, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Ralph P White Jr., MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, 200 C, Akron, OH 44333 Phone: 330-344-1260 Fax: 330-666-2632 |
Thomas G Olbrych, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Suite 100, Akron, OH 44304 Phone: 330-535-8850 Fax: 330-535-8859 |
Shanti Mikkilineni Akers, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Suite 210, Akron, OH 44304 Phone: 330-253-1411 Fax: 330-253-1720 |
Alyssa Jo Seabold, FNP-C Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |
Akhil Prutap Bindra, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Ste 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Matthew L Krauza, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Suite 210, Akron, OH 44304 Phone: 330-253-1411 Fax: 330-253-1720 |
Mohammad Salman Khan, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 White Pond Dr Ste 300, Akron, OH 44320 Phone: 330-253-1411 Fax: 330-253-1720 |
Dr. Joseph Elias Khabbaza, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W. Exchange St., Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Jonathan Troadio Azarcon Castro, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W. Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Dr. Amit Diwakar, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 W. Exchange St, Suite 380, Akron, OH 44302 Phone: 330-344-6676 Fax: 330-434-3611 |
Kenneth R Kretchmer, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 95 Arch Street, Suite 210, Akron, OH 44304 Phone: 330-253-1411 Fax: 330-253-1720 |
News Archive
Wyeth has announced that the jury in the cases of Janice Kydd v. Wyeth and Kathy Huber v. Wyeth in the Philadelphia Court of Common Pleas found in favor of Wyeth. The verdict came at the close of the first (damages) phase of this bifurcated (two-phase) trial.
Continuing the trend from previous years, the American College of Sports Medicine publishes two of the highest-ranked journals according to this year's edition of Thomson Reuters' Journal Citation ReportsĀ®.
A new study suggests that babies who are breast-fed or bottle-fed to a schedule do not perform academically as well at school as their demand-fed peers. The finding is based on the results of IQ tests and school-based SATs tests carried out between the ages of five and 14, which show that demand-feeding was associated with higher IQ scores.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
A promising type of vaccine designed to eradicate malaria by blocking parasite transmission could be a step closer, as a result of experts uncovering new information about the targeted protein.
› Verified 5 days ago